MTIGMaximum Time-in-Grade
References in periodicals archive ?
MTIG stated that Dr Blount replaces Tom DesRosier Esq, chief legal officer of Seres Therapeutics, who served as MTIG Chairman since the inception of the coalition in 2018.
Pharmaceutical and biotechnology companies pursuing regulatory approvals for microbiome therapeutics and microbiome-based products are eligible for consideration of membership in MTIG, which is comprised of three microbiome therapeutics companies: Rebiotix, Inc, Seres Therapeutics and Vedanta Biosciences.
According to MTIG, the human microbiome is a new frontier of medical innovation that may benefit patients suffering from numerous diseases.